Medscape’s editors are investigating what is needed to practice medicine in various countries around the world, and we want to hear from you! Medscape Reader Polls
Tag: News
US FDA Declines to Approve Outlook Therapeutics’ Eye Disease Drug, Shares Plummet
Outlook Therapeutics said on Thursday the U.S. health regulator has again declined to approve its experimental eye drug, citing a lack of substantial evidence of… Reuters Health Information
Diabetic Macular Edema: Second-Gen Anti-VEGFs Lead the Way
Medscape Medical News
Pill That Slows Aging? Meds May Boost Health Span
Metformin, rapamycin, and senolytics show multifaceted effects on aging biology that could transform how clinicians approach chronic disease prevention. Medscape Medical News
AMD Light Therapy Restores Vision Gains Post-Treatment Pause
A tabletop light therapy device led to vision improvements over 4.5 years and a long pause between treatments in people with dry age-related macular degeneration. Medscape Medical News
Simple, Noninvasive Eye Tracking May Flag Cognitive Decline
Naturalistic gaze patterns appear to be a simple, noninvasive, and reliable indicator of cognitive decline, new research suggests. Medscape Medical News
New Anti-VEGF Agents Extend Dosing Intervals in Wet AMD
New anti-VEGF agents for wet age-related macular degeneration can extend injection intervals to 3-5 months but may increase inflammation risk, prompting calls for tailored treatment plans. Medscape Medical News
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News
As Copay Aid Recedes, Retina Treatment ‘Unsustainable’
A new study finds cuts in copay assistance for retina injections are harming lower-income communities and leading to poorer vision outcomes. Medscape Medical News
Port Delivery System Outperforms Injections for DME
In patients with diabetic macular edema in both eyes, the port delivery system in one eye achieves a superior anatomical response than intravitreal injection the other, a new study shows. Medscape Medical News
Retina Tear Raises Detachment Risk After Cataract Surgery
Delaying cataract surgery 6 months or more after laser for retina tears reduces the risk for retinal detachment by half, a new study shows. Medscape Medical News
Veligrotug Shows Promise for Treating Thyroid Eye Disease
The THRIVE and THRIVE-2 clinical trials showed significant improvements in proptosis and diplopia in active as well as chronic thyroid eye disease, earning FDA Breakthrough Therapy designation. Medscape Medical News
Can Medicare Afford the Perpetual Human?
As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer and healthier life. Medscape Medical News
NIH Launches Agency-Wide Plan for Autoimmune Research
The 5-year strategy aims to accelerate diagnosis, prevention, and treatment for the millions living with autoimmune diseases in the US. Medscape Medical News
Identifying, Referring Cataracts in Primary Care
Cataracts can happen at any age, but risk is heightened in older adults and people with diabetes. Medscape Medical News
Study Finds Link Between IL-6 and Diabetic Eye Disease
A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be predictive of disease progression. Medscape Medical News
Study Finds Wide Pay Gaps in Eye Care
Inconsistent fees paid to doctors and facilities show the disadvantage independent clinicians face in the market. Medscape Medical News
Efficacy and Toxicity Seen With MIRV in Ovarian Cancer
New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in patients with platinum-sensitive ovarian cancer. Medscape Medical News
Novartis Drug Cosentyx Fails Late-stage Trial for Artery Disease
Novartis said on Thursday that its Cosentyx drug had failed in a late-stage trial on adults with giant cell arteritis (GCA), a condition characterised by inflammation of the… Reuters Health Information